A new study reports an antidepressant temporarily inhibits the blood-brain barrier, allowing drugs to enter the brain. The findings could have implications for treating neurological diseases from ALS to epilepsy.
Researchers have identified genetics mutations involved in a rare and unnamed neurological disorder.
According to researchers, combining tricyclic antidepressants with blood thinners increased tumor autophagy in mouse models of glioblastoma brain cancer.
Researchers believe the newly understood mechanism could yield insights into more precise future treatments for nerve pain and depression.